Skip to main content

Medical Marijuana Update

Submitted by Phillip Smith on (Issue #988)

A group of federal representatives tell Attorney General Sessions to quit blocking marijuana research, the White House wants data on Massachusetts medical marijuana patients, and more.

National

Last Thursday, a bipartisan group of federal lawmakers told Sessions to stop blocking marijuana research. Two Republican and two Democratic congressmen have sent a letter to Attorney General Jeff Sessions telling him to quit using the Justice Department to block medical marijuana research. In the letter signed by Reps. Earl Blumenauer (D-OR), Matt Gaetz (R-FL), Jared Polis (D-CO), and Dana Rohrabacher (R-CA), the congressmen referenced a recent report that Justice was blocking the DEA from moving forward on applications from scientists to cultivate marijuana for research purposes. Instead of delaying the application process, the congressmen wrote, "we encourage you to proceed with rapidity on the DEA's permitting process, as we believe it is in keeping with President Trump's campaign promises, and the best interests of the American people."

Maryland

On Monday, the state issued three more medical marijuana grower licenses. The state Medical Cannabis Commission issued final licenses to three more medical marijuana growers. The move came despite the growers missing a deadline earlier this month. Two other grower applicants were granted formal extensions. The state had given 15 companies a shot at the licenses; nine had already been approved. Now, with Monday's action, all but one of them are on track to supply the market.

Massachusetts

Last Friday, the White House was seeking data on state medical marijuana users. The National Marijuana Initiative, part of the Trump administration's anti-drug task force, has asked the state Department of Public Health to provide data on the health conditions cited by medical marijuana users. The department has already provided data on patient by age and gender, but said it was considering whether to hand over additional data.

Michigan

Last Thursday, regulators were seeking participants for stakeholder working groups. The state Bureau of Medical Marihuana Regulation is forming stakeholder working groups to help guide and set policy on regulations for a new law that will allow dispensaries in the state. The bureau is working with the Medical Marijuana Licensing Board to come up with regulations for areas including growing, processing, transport, and related issues. Click on the link for information about how to apply to participate.

Tennessee

Last Friday, legislative leaders announced they would study whether to legalize medical marijuana. Lt. Gov. Randy McNally (R) and House Speaker Beth Harwell (R-Nashville) announced in a that they are forming an ad hoc committee to study whether the state should legalize medical marijuana. The lawmakers said they would undertake a comprehensive review of the matter. The committee will consist of 10 legislators.

[For extensive information about the medical marijuana debate, presented in a neutral format, visit MedicalMarijuana.ProCon.org.]

Permission to Reprint: This content is licensed under a modified Creative Commons Attribution license. Content of a purely educational nature in Drug War Chronicle appear courtesy of DRCNet Foundation, unless otherwise noted.

Comments

Sam Abrams (not verified)

Medical marijuana has proved effective against a veriety of condtions inlcuding that terrible affliction of children Dravet's Syndrome.  Therre is even laboratory evidence that shiows that it kills cancer cells.

The government listing it as a Schedule One drug of no known medical use is insane, it goes agaisnt the evidence and prevents research that would save lives and end suffering for many people.

I urge all who are reading this to contact their senators and representative and demand that cannabis be removed from Scheduel One.

Sam Abrams  [email protected]

Thu, 08/31/2017 - 11:16am Permalink

Add new comment

The content of this field is kept private and will not be shown publicly.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.